After the cDNA of human macrophage migration inhibitory factor (MIF) was cloned in 1989, this protein has been reevaluated as a pro-inflammatory cytokine, pituitary hormone and glucocorticoid-induced immunoregulatory protein. We previously reported the expression of MIF in the basal cell layers of the epidermis, but its pathophysiological function in the skin has not been well understood. In this study, we examined the expression of MIF during the wound healing of rat skin injured by excision. Reverse transcription-polymerase chain reaction in combination with Southern blot analysis revealed that the increase of MIF mRNA expression was biphasic. The maximum peaks were observed at 3 and 24 h after the injury. Similarly, maximal increases of the serum MIF level were observed at 3 and 24 h after the injury. Immunohistochemical analysis at 12 h after injury demonstrated enhanced expression of MIF protein in the whole epidermal lesion of the wound tissue. By the Boyden chamber assay, we demonstrated that MIF had a chemotactic effect on freshly prepared keratinocytes from rat skin. Additionally, cultured fibroblasts from the skin wound lesion secreted a higher amount of MIF in response to lipopolysaccharide compared to those of the normal skin. Furthermore, administration of anti-MIF antibodies induced a delay of wound healing in vivo. Taken together, these results suggest that MIF contributes to the wound healing process of skin tissue. ß
Introduction
Evidence is emerging that a variety of cytokines are involved in cutaneous in£ammatory and immunological reactions [1] . Release of cytokines by ker-atinocytes can be induced by a number of environmental factors, including trauma, ultraviolet light and bacterial endotoxins. Macrophage migration inhibitory factor (MIF) was the ¢rst lymphokine reported to prevent the migration of macrophages out of capillary tubes [2] . Recently, it was reported that MIF mRNA expression was up-regulated during peripheral nerve regeneration, suggesting its involvement in wound healing [3] . The process of wound healing is complex, consisting of in£ammation, granulation and remodeling of tissues. Several growth factors/cytokines play an important role in tissue repair and enhance the wound healing process [4] . In this context, MIF induced in cases of tissue damage is considered to contribute to the in£ammatory and immunological responses.
In 1989, human MIF cDNA was cloned for the ¢rst time from activated T-cells [5] . Following this, MIF genes of other species, including the mouse and rat, were cloned [6, 7] . After the cloning, extensive molecular-based studies on MIF have been performed. Recent ¢ndings demonstrated that MIF functions as an initiator of in£ammation via regulation of a number of pro-in£ammatory cytokines, including tumor necrosis factor (TNF)-K, interleukin (IL)-1 and IL-6 [8^10] . We demonstrated the expression and tissue localization of MIF in various tissues such as epithelial and endothelial cells of the cornea, reproductive organs, osteoblasts and kidney [11^14] . At present, MIF is known to function as a pituitary hormone and glucocorticoid cytokine as well as an immunomodulatory protein and is believed to be associated with broad-spectrum biological responses beyond the immune system [15] .
As for the skin, we demonstrated the presence and tissue localization of MIF in the basal layers of human epidermis [16] . We identi¢ed a high expression of MIF in atopic dermatitis and showed that MIF is an immunoregulatory protein in the pathophysiology of this skin disease [17] . We also showed that totalbody ultraviolet B exposure in vivo increased the production of MIF, suggesting its involvement in tissue injuries [18] . From these previous ¢ndings, it is conceivable that MIF might be associated with in£ammation and wound healing processes in various skin disorders. In this study, we examined MIF expression during the wound healing process of rat skin. Following this, we assessed the e¡ect of MIF on keratinocyte migration in vitro and evaluated the e¡ects of anti-MIF antibodies on wound repair in vivo.
Materials and methods

Materials
The following materials were obtained from commercial sources. Isogen RNA extraction kit from Nippon Gene (Tokyo, Japan); M-MLV reverse transcriptase, trypsin-EDTA and fetal calf serum (FCS) from Gibco (Grand Island, NY, USA); Taq DNA polymerase from Perkin-Elmer (Norwalk, CO, USA); horseradish peroxidase-conjugated goat antirabbit antibody from Pierce (Rockford, IL, USA); Vector ABC kit from Vector Laboratories (Burlingame, CA, USA); lipopolysaccharide (LPS) (0111: B4) from Difco (Detroit, MI, USA); type I collagenase from Sigma (St. Louis, MO, USA); Protein A Sepharose from Pharmacia (Uppsala, Sweden); Tissue-Tek O.C.T compound from Miles Scienti¢c (Elkhart, MN, USA); polyvinyl alcohol sponges from Mentor (Mingham, MA, USA); cellulose acetate membrane ¢lter (8 Wm pores) from Kurabo (Osaka, Japan); non-immune rabbit IgG and £uorescein isothiocyanate-conjugated goat anti-rabbit IgG from Zymed (San Francisco, CA, USA) and random primer £uorescein labelling kit and nucleic acid chemiluminescence reagent from DuPont NEN (Boston, MA, USA). All other chemicals were of analytical grade.
A polyclonal anti-rat MIF antibody was generated by immunizing New Zealand white rabbits with pu-ri¢ed recombinant rat MIF [19] and its speci¢city to MIF protein was con¢rmed by Western blot analysis as described [20] . The IgG fractions (4 mg/ml) were prepared using Protein A Sepharose according to the manufacturer's protocol.
Preparation of rat skin tissues
All experiments were carried out on 7-week-old Wistar King female rats weighing 150^170 g each. The rats were anesthetized by a combination of ketamine and xylazine. After the abdominal surfaces were shaved and wiped with 30% isopropyl alcohol, six full-thickness wounds (6 mm diameter) on the skin were made by excising the skin. The wounds were allowed to be dry in order to form a scab. Following killing with a pentobarbital overdose, the skin specimens were harvested 1, 3, 6, 12, 24 or 48 h after the injury. An area 1 mm in diameter, including the complete epithelial margins, was excised at each time point. Control rats were treated in a similar manner without making wounds after the abdominal surfaces were carefully shaven. Similar amounts of the skin tissues from the abdominal walls of nonwounded rats were obtained at the indicated intervals as a control. The tissues were immediately fro-zen in liquid nitrogen and stored at 380³C until used for total RNA extraction.
Fibroblast culture
Wound ¢broblasts were obtained from the granuloma of injured skin lesions attached to polyvinyl alcohol sponges (5U5U30 mm 3 a piece) as described [21] . In brief, the polyvinyl alcohol sponges were placed under aseptic conditions into the £anks of the rats. The sponges were allowed to stay for approximately 2 weeks, aseptically removed, minced into ¢ne pieces and subjected to 4^6 h incubation with collagenase (200 U/ml). At the end of collagenase digestion, the tissue specimens were subjected to trypsin-EDTA treatment for 3 min. The cells were then washed twice, plated in culture £asks and allowed to grow to con£uence.
Normal dermal ¢broblasts were obtained from the dorsal skin surface of the rat. The back of the rat was carefully shaven, a segment of skin was excised and ¢broblasts were obtained by the standard explant technique as described [22] . Brie£y, the skin was cut into 3^5 mm pieces and placed onto large petri dishes with the subcutaneous side down. Once a su¤cient number of ¢broblasts had migrated out from the skin sections, pieces of the skin were removed and the cells were passaged by trypsin digestion in the same manner as for the wound-harvested ¢broblasts. Both the normal and the wound-harvested ¢broblasts were grown in DMEM containing 10% FCS and penicillin/streptomycin. The cells of passages 2^4 were used for the experiment.
LPS stimulation
Cells were passaged twice prior to stimulation with LPS. Immediately prior to stimulation, media containing 10% FCS were removed and 1 Wg/ml of LPS was added to serum-free DMEM. Supernatants were collected 48 h after the stimulation and subjected to an enzyme-linked immunosorbent assay (ELISA) for MIF.
Reverse transcription-polymerase chain reaction (RT-PCR) and Southern blot analysis
The skin specimens were surgically obtained from the wound and normal rats as described above. Total RNA was extracted from the specimens with an Isogen RNA extraction kit. The reverse transcription of RNA was carried out using M-MLV reverse transcriptase with oligo-dT primers and subsequent am-pli¢cation using Taq DNA polymerase. For analysis of the MIF mRNA expression level, we preliminarily examined the kinetics of MIF mRNA ampli¢cation by semi-quantitative RT-PCR/Southern blot analysis. The ampli¢cation of MIF mRNA remained in the exponential phase up to at least 23 cycles. Since the ampli¢cation products at 23 cycles could not be visualized on an electrophoresed agarose gel stained with ethidium bromide, we carried out Southern blot hybridization to detect and quantify the ampli¢ed products. As for glyceraldehyde-3-phosphate-dehydrogenase (G3PDH), linearity was similarly obtained at 23 cycles and ampli¢cation was carried out in the same way. In brief, the PCR was carried out for 23 cycles of denaturation at 94³C for 1 min, annealing at 53³C for 2 min and extension at 72³C for 1 min using a thermal cycler (Perkin-Elmer, Model 2400). The primers for MIF were 5P-CACCA-TGCCTATGTTCATCGTGAACA-3P (34^22, forward) and 5P-AACGGTTCCACCTTCGCTTGAG-CCCGGGC-3P (325^351, reverse) and those for G3PDH were 5P-TGAAGGTCGGTGTCAACG-GATTTGGC-3P (5^30, forward) and 5P-GTGG-TGGACCTCATGGCCTACATG-3P (964^987, reverse). For numbering of the primers, the initial nucleotide of the initiator methionine was designated +1. The PCR products were separated on a 2% agarose gel and transferred onto a nylon membrane by capillary action. The DNA was immobilized on the membrane by baking at 80³C for 2 h. The DNA probes for MIF and G3PDH were prepared using the full-length rat MIF and G3PDH cDNA insert labelled with a £uorescein labelling kit according to the manufacturer's protocol. 
Immunohistochemistry
The samples from the rat skin at 12 h after injury were immediately embedded in O.C.T. compound, snap frozen in liquid nitrogen and stored at 380³C until further processing. The frozen embedded tissues were cut into 4 Wm sections and then ¢xed in acetone for 10 min at room temperature and subjected to immunohistochemical analysis as described previously [12] . As a control, we used non-immune rabbit IgG to exclude non-speci¢c staining.
ELISA
The injured and non-injured rats were killed by an overdose of pentobarbital, blood of each rat was obtained from the left ventricle and sera were prepared. The sera as well as supernatants of cultured ¢broblasts were subjected to ELISA for measurement of MIF as previously described [12] . For this assay, we used recombinant rat MIF to obtain the standard curve, in which good linearity was demonstrated between MIF contents (0.5^200 ng/ml) and absorbancy.
Chemotaxis assay
To evaluate the e¡ect of MIF on keratinocyte migration, a modi¢cation of the Boyden chamber assay was performed as previously described [23] . Brie£y, the lower well was ¢lled with 600 Wl of medium (DMEM containing 10% FCS) in the presence of various amounts of MIF. The upper well contained the cell suspension (400 Wl, 1U10 5 cells/ml medium). A cellulose acetate membrane ¢lter was interposed between the two chambers. The chambers were kept in a humidi¢ed atmosphere of 5% CO 2 at 37³C for 4 h. Filters were subsequently ¢xed with methanol and acetone and stained with crystal violet. The number of cells that migrated into the ¢lter and reached its lower side was determined microscopically. Three chambers were set up for each assay, ¢ve ¢elds were counted on each ¢lter and the counts were expressed as means with S.D. In each experimental group, a negative control (medium) was run.
Wound healing experiments
For wound healing experiments, mice (C57/BL6, female 6^8 weeks), weighing 25^30 g, were anesthetized with sodium pentobarbital solution (40 mg/kg, intraperitoneal (i.p.)) and their dorsal hair was clipped. Four penetrating wounds through both the epidermis and dermis were prepared on the upper back of each mouse using a punch biopsy instrument (4 mm diameter). The four wounds were separated by 1 cm. The wounds were left open during the experiments. Anti-rat MIF antibodies (5 mg/kg) which cross react with mouse MIF [6, 7] or non-immune rabbit IgG were injected i.p. (5 mg/kg) every 2 days (starting on day 0) until wound healing was completed. We examined the appearance of the skin wound lesions until the epithelial surface was restored.
Statistics
Statistical analyses on the MIF levels in the culture media of the normal and wounded ¢broblasts and of the keratinocyte migration by the Boyden chamber assay were performed using Student's t-test and the Mann-Whitney U-test, respectively. P 6 0.05 was considered to be signi¢cant.
Results
Induction of MIF mRNA during wound healing
We examined the expression of MIF mRNA in the wound healing of rat skin by RT-PCR/Southern blot analysis until 48 h after injury. The results showed a biphasic increase of MIF mRNA (Fig. 1) . In detail, the MIF mRNA expression level was signi¢cantly elevated at 1 h after the injury and reached the maximal level at 3 h (ca. 1.8-fold) and rapidly decreased at 6 h. Then, the MIF expression was again increased at 24 h (ca. 2.6-fold) after the injury and decreased at 48 h. As an internal control, the mRNA of G3PDH was measured.
MIF content in sera during wound healing
The serum MIF protein concentration of the in-jured rats was measured at regular intervals. The results showed a similar biphasic increase in the expression of MIF mRNA (Fig. 2) . The serum content before the injury was 8.1 þ 1.8 ng/ml. The ¢rst peak was observed at 3 h (56.8 þ 9.9 ng/ml) after the skin injury with a signi¢cant di¡erence, but rapidly decreased at 6 h after injury. The second peak of MIF protein was identi¢ed at 24 h (56.7 þ 15.0 ng/ ml) after the injury and gradually decreased at 48 h. Since £uorescence-labelled MIF was taken up by melanoma cells and macrophages in vitro (unpublished observation), it was speculated that the transient decrease of MIF between 6^24 h, even if not completely, might be attributable to the uptake by cells of various organs in vivo.
Immunohistochemical localization of MIF in wounded rat skin
Immunohistochemical analysis was carried out on the tissues obtained at 12 h after injury. It was re-vealed that MIF-positive staining was mostly observed in the basal layer of the control (Fig. 3A) as previously demonstrated [16] . On the other hand, extensive positive staining was observed in all the layers of the epidermis that reacted with the anti-MIF antibody after the injury (Fig. 3B ). In addition, some positive mononuclear cells were also observed in the dermis. The positive staining was not detected when non-immune IgG was used (Fig. 3C ).
MIF expression of cultured wound ¢broblasts
Fibroblasts play an important role in the wound healing process of the skin, equal to that of keratinocytes. For examining the process of wound healing, LPS has sometimes been used as a stimulant and the mechanism of in£ammatory and immune responses in the event of tissue damage has been evaluated [21, 24] . To determine whether the wound ¢broblasts and the normal dermal ¢broblasts could secrete MIF in response to LPS, we measured the MIF content in the media of both the wound and normal dermal ¢broblasts in response to LPS stimulation under serum-free conditions. Fig. 4 shows that MIF secretion by the wound ¢broblasts was signi¢cantly higher than that of normal dermal ¢broblasts with and without stimulation. The wound ¢- broblasts treated with LPS for 48 h signi¢cantly increased secretion of the MIF protein into the culture medium (2.9 þ 0.2 ng/ml) compared to normal dermal ¢broblasts (0.8 þ 0.1 ng/ml).
Chemotactic e¡ect of MIF on keratinocyte migration
Migration of keratinocytes is an important event for wound healing of the skin. To assess the role of MIF in wounds, freshly separated rat keratinocytes obtained from wound lesions were tested for chemotactic activity of this protein. We added various doses of MIF in the lower chamber at concentrations of 1, 10 and 100 ng/ml. A signi¢cant increase of keratinocyte migration was observed at the highest dose of MIF (100 ng/ml) ( Fig. 5 ). Since the MIF concentration is increased at the level of 80^120 ng/ ml at loci such as synovial £uids and follicular £uids [25, 26] , it is conceivable that the local MIF concentration at the site of skin wounds might reach these levels to induce keratinocyte migration in vivo. 
E¡ect of anti-MIF antibody on wound healing of the skin
We observed that the reparative pattern was characterized by formation of a dehydrated wound crust, gradual loss of the lesion surface, appearance of a thin residual skin defect, closure of the wound surface and re-appearance of the epithelial surface. We examined the appearance of round skin wounds after treatment with anti-MIF antibodies to assess the role of MIF in the wound healing process. Complete healing was seen between 5 and 9 days after the surgery for the control mice injected with non-immune IgG, whereas it was seen between 11 and 15 days for the mice injected with anti-MIF antibodies (Fig. 6 ). This fact indicated that MIF played an important role in the wound healing process.
Discussion
We demonstrated increased MIF expression in the wound healing process and MIF production by wound ¢broblasts was increased by LPS. MIF acted as a chemoattractant for keratinocytes. Moreover, it should be noted that the wound healing process was signi¢cantly delayed by administration of anti-MIF antibody in vivo. These ¢ndings strongly indicated that pluripotent MIF could play a critical role in skin injury, a¡ecting cutaneous immunity, in£ammation and cell growth.
Numerous investigations have demonstrated that several cytokines play pivotal roles in the pathophysiology of the normal skin and related diseases [1] . For example, IL-1K, which is produced by keratinocytes and other cells, stimulates the growth of ¢broblasts and keratinocytes, collagen synthesis by ¢broblasts and chemotaxis of keratinocytes in tissue injuries [27] . The wound healing process of the skin is complex, consisting of clotting, in£ammation, ¢broplasia, neovascularization, wound contraction and tissue remodeling, in which collaborative actions of many di¡erent tissues and cell lineages are required [28] . Histologically, migration of keratinocytes from the wound edges and their subsequent proliferation are essential for wound repair [29] . In this process, cytokines and other in£ammatory mediators released from keratinocytes govern this event by regulating the growth, di¡erentiation and metabolism of the various cells in the injured skin lesion [4] .
After discovery of MIF activity in the culture supernatant of activated T-cells [30] , various biological activities of MIF were reported. However, the MIF gene was long unidenti¢ed. In 1989, human MIF cDNA was cloned for the ¢rst time from activated T-cells, although this molecule was found to be distinct from the previously known MIF molecules and found to be a novel protein with respect to amino acid sequences. Following this, MIF genes of various species were isolated, including mouse, rat and chicken [6, 7, 31] .
After the molecular cloning of MIF, this protein was rediscovered as an immunomodulatory cytokine induced by a number of stimuli such as LPS, modulates in£ammatory and immunological responses and functions as an initiator of in£ammatory and immunological reactions by regulating production of a number of cytokines, including TNF-K, IL-1 and IL-6 [8, 9] . In this study, we demonstrated for the ¢rst time up-regulation of MIF in the wound healing keratinocytes by immunohistochemical and RT-PCR/Southern blot analyses. In parallel, we showed that the serum MIF level was increased. The source of elevated serum MIF was not clearly identi¢ed, but it is very likely that keratinocytes and ¢broblasts in the wound skin are the major sources. Moreover, we found elevation of MIF production by cultured wound ¢broblasts. It is known that ¢broblasts contribute to wound healing. Endotoxin administration a¡ects the expression of MIF protein and mRNA in various tissues of the rat [10] , but no precise examination of MIF functions has been performed in the skin. This is the ¢rst evidence demonstrating up-regulation of MIF in cultured ¢broblasts in response to LPS. In association with the source of serum MIF, it was reported that MIF was readily secreted from the pituitary in response to various stimuli such as endotoxins as a counter-regulator of glucocorticoid [32] . Accordingly, the elevation of the serum MIF content may also have originated from the pituitary.
Investigations focused on the role of ¢broblast-secreted cytokines in in£ammatory responses have recently been carried out, because ¢broblasts have been regarded as candidate cells for the production of various cytokines and growth factors found in the wound milieu. Indeed, cultured ¢broblasts obtained from wound lesions are capable of secreting TNF-K after LPS stimulation [21] . To date, several reports support the idea that ¢broblasts have the potential to secrete a broad range of cytokines and growth factors, including IL-1, IL-6 and colony-stimulating factors [33] . Since TNF-K up-regulates MIF production of macrophages and various other types of cells [343 6] and vice versa [9] , the presence of an amplifying pro-in£ammatory loop response between the two cytokines is hypothesized. Cell proliferation and di¡erentiation are essential for wound healing. The possible involvement of MIF in cell di¡erentiation and proliferation has been reported. For example, MIF is present in highly proliferative tissues such as the corneal epithelium [12] , basal cell layers of skin epidermis [16] , osteoblasts [13] , leukemia cells [37] and the early embryonal chicken lens [31] . MIF may a¡ect cellular proliferation as a growth factor-induced delayed early response gene [38] . We recently found that the MIF mRNA of the injured cornea was up-regulated at 6 h after injury [20] . This ¢nding supported the idea that MIF is associated with the acute phase of the wound healing process and is consistent with our present results on the skin injury. Therefore, up-regulation of MIF after the injury as a delayed early response gene appears to be reasonable. Furthermore, we observed that antisense MIF plasmid transfection suppressed the growth of tumor cells and the morphological changes of these cells (unpublished data). Although the precise mechanism of the molecular function of MIF in relation to cell growth remains to be elucidated, these ¢ndings support the idea that excessive expression of MIF may directly or indirectly stimulate cell proliferation, which modulates the wound healing process.
Finally, the reparative response to a skin wound is accompanied by migration of keratinocytes, which contributes to wound repair. We here demonstrated that MIF had the potential to induce keratinocyte migration in vitro and, moreover, anti-MIF antibody caused a delay in the closure of the skin wound. In this context, it is considered that MIF may play an important role in the skin wound healing process. The pathophysiological function of MIF should thus be a major target of research in association with wound healing of the skin.
